One Year Data from the Sonic Study: A Randomized, Double-Blind Trial Comparing Infliximab and Infliximab Plus Azathioprine to Azathioprine in Patients with Crohn's Disease Naive to Immunomodulators and Biologic Therapy

被引：0
|
作者：
Sandborn, William J.
Rutgeerts, Paul J.
Reinisch, Walter
Mantzaris, Gerassimos J.
Kornbluth, Asher
Rachmilewitz, Daniel
Lichtiger, Simon
D'Haens, Geert R.
van der woude, Christien J.
Diamond, Robert
Broussard, Delma
Tang, Kezhen L.
Colombel, Jean-Frederic
机构：
来源：
GASTROENTEROLOGY | 2009年 / 136卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A116 / A116
页数：1
相关论文
共 50 条
  • [1] SONIC: A randomized, double-blind, controlled trial comparing Infliximab and Infliximab plus Azathioprine to Azathioprine in patients with Crohn's Disease naive to immunomodulators and biologic therapy
    Sandborn, W.
    Rutgeerts, P.
    Reinisch, W.
    Mantzaris, G.
    Kornbluth, A.
    Rachmilewitz, D.
    Lichtiger, S.
    D'Haens, G.
    van der Woude, C.
    Diamond, R.
    Broussard, D.
    Hegedus, R.
    Colombel, J.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S1 - S1
  • [2] Sonic: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to Immunomodulators and biologic therapy
    Sandborn, W.
    Rutgeerts, P.
    Reinisch, W.
    Kornbluth, A.
    Lichtiger, S.
    D'Haens, G.
    van der Woude, C.
    Diamond, R.
    Broussard, D.
    Colombel, J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S436 - S436
  • [3] SONIC Study. A Randomized, Double-Blind Trial Comparing Infliximab and Infliximab plus Azathioprine to Azathioprine in Patients with Crohn's Disease Naive to Immunomodulators and Biologic Therapy
    Sandborn, W.
    Rutgeerts, P.
    Reinisch, W.
    Mantzaris, G.
    Kornbluth, A.
    Rachmilewitz, D.
    Lichtiger, S.
    D'Haens, G.
    van der Woude, C.
    Diamond, R.
    Broussard, D.
    Tang, K.
    Colombel, J.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S13 - S13
  • [4] Infliximab plus azathioprine for steroid-dependent Crohn's disease patients:: A randomized placebo-controlled trial
    Lémann, M
    Mary, JY
    Duclos, B
    Veyrac, M
    Dupas, JL
    Delchier, JC
    Laharie, D
    Moreau, J
    Cadiot, G
    Picon, L
    Bourreille, A
    Sobahni, I
    Colombel, JF
    GASTROENTEROLOGY, 2006, 130 (04) : 1054 - 1061
  • [5] Steroid-independent Crohn's disease patients also benefit from combination therapy of infliximab plus azathioprine
    Van Den Brande, Jan M. H.
    Peppelenbosch, Maikel P.
    GASTROENTEROLOGY, 2006, 131 (04) : 1362 - 1363
  • [6] Combination therapy with metronidazole and azathioprine reduces severe postoperative recurrence of Crohn's disease: A double-blind controlled randomized trial
    D'hatens, Geert R.
    Noman, Maja
    Van Assche, Gen A.
    Van Olmen, Gust
    Aerden, Isolde
    Vermeire, Severine
    Rutgeerts, Paul J.
    GASTROENTEROLOGY, 2007, 132 (04) : A52 - A52
  • [7] Evolution of Endoscopic Activity Scores in Patients With Crohn's Disease Under Azathioprine and/or Infliximab: A Post-Hoc Analysis of the Sonic Data
    Ferrante, Marc
    Colombel, Jean-Frederic
    Sandborn, William J.
    Reinisch, Walter
    Mantzaris, Gerassimos J.
    Kornbluth, Asher
    Rachmilewitz, Daniel
    Lichtiger, Simon
    D'Haens, Geert R.
    Diamond, Robert
    Oortwijn, Alessandra Faria
    Tang, Kezhen L.
    van der Woude, Christien J.
    Rutgeerts, Paul J.
    GASTROENTEROLOGY, 2011, 140 (05) : S422 - S422
  • [8] Addition of Metronidazole to Azathioprine for the Prevention of Postoperative Recurrence of Crohn's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
    Manosa, Miriam
    Cabre, Eduard
    Bernal, Isabel
    Esteve, Maria
    Garcia-Planella, Esther
    Ricart, Elena
    Penalva, Mireia
    Cortes, Xavier
    Boix, Jaume
    Pinol, Marta
    Gassull, Miquel A.
    Domenech, Eugeni
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (09) : 1889 - 1895
  • [9] Azathioprine for prevention of clinical recurrence in Crohn's disease patients with severe endoscopic recurrence: an IG-IBD randomized double-blind trial
    Orlando, A.
    Mocciaro, F.
    Ventimiglia, M.
    Renna, S.
    Rispo, A.
    Scribano, M. L.
    Testa, A.
    Aratari, A.
    Bossa, F.
    Angelucci, E.
    Onali, S.
    Cappello, M.
    Giunta, M.
    Scimeca, D.
    Macaluso, F.
    Castiglione, F.
    Papi, C.
    Annese, V
    Biancone, L.
    Kohn, A.
    Di Mitri, R.
    Cottone, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (21) : 11356 - 11364
  • [10] Steroid-independent Crohn's disease patients also benefit from combination therapy of infliximab plus azathioprine (vol 131, pg 1362, 2006)
    Van den Brande, J. M. H.
    Peppelenbosch, M. P.
    GASTROENTEROLOGY, 2007, 132 (01) : 466 - 466
12345